Photo Gallery (All Days)
Monday, July 11, 2016
Tuesday, July 12, 2016
Increased commercial activity in space has gradually transformed low Earth orbit into an emerging market. This session will focus on four development areas—biological and pharmaceutical, Earth imaging, materials science, and space transportation—where companies are finding and targeting customer groups that have the potential to develop into market sectors in low Earth orbit.
This special keynote presentation will feature a conversation between Dr. Sanjay Gupta, CNN’s Chief Medical Correspondent, and former NASA Astronauts Scott and Mark Kelly. The discussion will focus on Scott Kelly’s “Year in Space” mission, the impact of the Twins Study, and how ISS research is advancing personalized medicine to benefit life on Earth.
Attendees at the 2016 ISS Research and Development Conference, which took place on July 12-14, 2016 in San Diego, CA, offer their views on the importance of this annual meeting and the impact of the ISS National Lab.
Wednesday, July 13, 2016
As the commercial space sector continues to diversify and new users drive a growing demand for increased technological capabilities and services, it is clear that innovation is essential for long-term success in commercial spaceflight. Tory Bruno, President and CEO of United Launch Alliance (ULA), will share his thoughts on the evolving landscape of commercial space and highlight opportunities for innovation that will propel the commercial space industry to new levels of affordable space access.
Virtual reality has the potential to drive unprecedented social impact—truly demonstrating to the world how the International Space Station is a platform for technology advancement and a remarkable gateway to new possibilities. Oculus VR is producing historic never-before-seen immersive content in virtual reality that makes the dream of space exploration a reality to people everywhere with the Oculus platform and Facebook 360 video. This session will explore how consumer virtual reality is changing innovation and technology advancements here on Earth and enabling space presence for all.
NASA’s International Space Station Program is pursuing strategic efforts to maximize ISS research to increase laboratory throughput and repeated research opportunities, attract new users, and further utilize the ISS as a proving ground for viable commerce in space. This panel will feature existing ISS users and NASA’s ISS Program management team discussing current research, the evolution of the ISS Program, and how space commercialization, via the ISS, is connected to NASA’s vision for exploration.
This session will highlight the active work of students and young professionals on the ISS. These next-generation researchers will discuss their experiences in translating their ground studies into spaceflight experiments, the benefits of microgravity research, and the overall impact of their research endeavors.
The mission of the International Space Station is to advance science and technology research, inspire the next generation of explorers, and serve as a platform for innovation to foster the commercial development of space. As Mr. Brandon Farwell of Rothenberg Ventures will illustrate, investments in disruptive frontier-technologies such as virtual reality, artificial intelligence, robotics, and 3D printing, have sparked accelerated R&D and/or mass market adoption, and have found new applications on the ISS and beyond. The luncheon keynote speaker, Dr. Peter H. Diamandis, Founder and Executive Chairman of the XPRIZE Foundation, will feature the disruptive power of exponentially growing technologies and how the commercial development of space is playing a role in the future of innovation. Finally, Mr. Chris Lewicki, President and CEO of Planetary Resources, invites us to explore asteroid mining as a catalyst to spark the space economy.
In an era of increasing human longevity, it is becoming ever more critical to prioritize not only improved treatment of disease but also approaches for maintaining wellness to preserve the quality of life for aging adults. Spaceflight- induced physiological changes represent deviations from this state of wellness, with some changes serving as accelerated models of Earth-based conditions, including musculoskeletal disease, immune dysfunction, and delayed wound healing. This session will highlight research onboard the ISS National Lab that seeks to exploit these spaceflight-induced physiological effects to improve human health on Earth through studies that advance the prevention, detection, and treatment of disease. In parallel, spaceflight research and development efforts also seek to improve the human condition by employing the space environment to advance diagnostic tools and drug discovery, development, and delivery systems.
Thursday, July 14, 2016
This session will consider and discuss the role played by the International Space Station as an exploration testbed and in creating markets that extend beyond low Earth orbit (LEO). The ISS is a critical technical testbed for deep-space exploration system and subsystem development and as a testbed for the development of business in space that might be sustained in LEO or beyond, once the ISS is gone. Panelists will consider international partnerships; the development of specialized equipment or facilities; customer expectations; and the development of human-operated, human-tended, autonomous or passive platforms in LEO or in Cislunar space.
By the end of 2017, NASA plans to purchase both crew and cargo delivery services to the International Space Station from commercial suppliers. Near the planned end-of-life for ISS, NASA intends to transition low Earth orbit (LEO) operations from government-led to commercially-driven as a result of greater involvement from the private sector. CASIS has seen increasing demand for use of the ISS National Lab to support research and development in numerous fields. This session will highlight the R&D opportunities in low Earth orbit ranging from LEO commercialization efforts related to advancing protein crystal growth studies for drug discovery and delivery; stem cell, organs-on-chips, and vascularized tissue research for organ bioengineering; and use of 3D printing capabilities and superior optical fiber manufacturing for on-orbit production.
This session explores the barriers that women face when pursuing education and careers in science, technology, engineering, and mathematics. The featured panel represents three generations of women whose work has been centered on the International Space Station. They will share and discuss the experiences, inspirations, opportunities, and strategies that enabled them to break through gender barriers and discuss methods for addressing and eliminating them in the future.
Genes in SpaceTM named Julian Rubinfien, a high school student from New York, the winner of the second annual Genes in SpaceTM competition. The innovative contest challenges students in grades seven through 12 to design an experiment to solve a real-life space exploration problem through DNA analysis. The winning experiment will be conducted aboard the International Space Station (ISS) using miniPCR™ technology.
NASA Astronaut Josh Cassada will join the 2016 ISS R&D Conference for a special luncheon presentation. Cassada, a physicist by training, was selected in NASA’s 21st Astronaut class in 2013. He is currently in astronaut training for a future spaceflight mission. During his presentation, Cassada will give an inspirational overview of his journey to becoming an astronaut and highlight the current training that is preparing him to reach the International Space Station and beyond.
The Genes in Space competition challenges students in 7-12th grades to design an experiment that can solve a space exploration problem through DNA analysis. This session will present the results from last year’s winning experiment that tested the polymerase chain reaction to study epigenetic changes aboard the ISS. Meet the 17-year-old high school student who led the first successful DNA amplification in space as well as the 2016 Genes in Space Finalists.